News Focus
News Focus
icon url

Ecomike

09/17/20 2:16 PM

#16912 RE: mick #16909

Not sure I understand the question?

52 week MA is about $4/share

52 and 10 week high $10.60 and earlier this year $10/share on one rally and $9+ on 2-3 rallies pre split basis.

We all held through the R/S 1:1000 that dropped the float to 290,000 shares

Ticker changed about 8 weeks ago, and has only traded about8-10 weeks since the R/S-Ticker change was over and we got out shares back (about 9 weeks ago).

It was custodial clean shell late last year....

Custodian returned 65% of the OS to the treasury, then R/S his own shares and ours (retail float now 290K shares).

He knew what is coming or he would not have $11,000 cash he paid to Nevada to get the company current, and taken shares, then returned 80% of his shares and then sat through a 1:1000 R/S with us, if he did know a billion dollar biotech was inbound.

They changed the company name 6 months ago in Nevada SOS, and from that we found a web site URL bought by Larry Kubin that tied the website to this company, and the web site went live 1-2 weeks ago.

2 days ago old data on the old company was removed from the Nevada SOS site, about 11 year old prior company.

icon url

Ecomike

09/17/20 2:26 PM

#16914 RE: mick #16909

If they do an SEC 1-A the stock price can be lower than $4/share to uplist to NYSE with a $40/mil dollar cash raise.

But they could do it at $30/share IMHO. Thus better valuing the Billion dollar biotech they are bringing.